Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome | Zendy

Konstantinos A. Toulis | Zendy; Dimitrios G. Goulis | Zendy; Gesthimani Mintziori | Zendy; Evangelia Kintiraki | Zendy; Evangelos Eukarpidis | Zendy; Sophia-Anastasia Mouratoglou | Zendy; Antigoni Pavlaki | Zendy; Stavros Stergianos | Zendy; Maria Poulasouchidou | Zendy; Thrasyvoulos Tzellos | Zendy; Anastasios Makedos | Zendy; Michail Chourdakis | Zendy; Basil C. Tarlatzis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome

Author(s) -

Konstantinos A. Toulis,

Dimitrios G. Goulis,

Gesthimani Mintziori,

Evangelia Kintiraki,

Evangelos Eukarpidis,

Sophia-Anastasia Mouratoglou,

Antigoni Pavlaki,

Stavros Stergianos,

Maria Poulasouchidou,

Thrasyvoulos Tzellos,

Anastasios Makedos,

Michail Chourdakis,

Basil C. Tarlatzis

Publication year - 2011

Publication title -

human reproduction update

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.977

H-Index - 180

eISSN - 1362-4946

pISSN - 1355-4786

DOI - 10.1093/humupd/dmr025

Subject(s) - polycystic ovary , asymmetric dimethylarginine , medicine , homocysteine , plasminogen activator inhibitor 1 , endothelial dysfunction , endocrinology , fibrinogen , plasminogen activator , c reactive protein , lipoprotein(a) , insulin resistance , gastroenterology , diabetes mellitus , lipoprotein , cholesterol , inflammation , biology , arginine , biochemistry , amino acid

The relation between polycystic ovary syndrome (PCOS) and cardiovascular disease (CVD) remains unclear. In an attempt to provide high-quality evidence on the relation between PCOS and CVD, relevant literature for CVD risk markers [C-reactive protein (CRP), homocysteine (Hcy), tumor necrosis factor-alpha (TNF-α), plasminogen activator inhibitor-1 (PAI-1), lipoprotein (a) [Lp(a)], advanced glycation end-products (AGEs), vascular endothelial growth factor (VEGF), interleukin-6 (IL-6), asymmetric dimethylarginine (ADMA), endothelin-1 (ET-1) and fibrinogen] in women with PCOS was reviewed and analyzed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research